PharmaResearch Co Ltd
KOSDAQ:214450
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
241 000
711 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
Price Targets Summary
PharmaResearch Co Ltd
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 781 632.33 KRW with a low forecast of 646 400 KRW and a high forecast of 1 245 365.21 KRW.
Price Targets
Operating Income
Forecast
Operating Income Estimate
PharmaResearch Co Ltd
For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 27%. The projected CAGR for the next 3 years is 43%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PharmaResearch Co Ltd's stock price target?
Price Target
781 632.33
KRW
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 781 632.33 KRW with a low forecast of 646 400 KRW and a high forecast of 1 245 365.21 KRW.
What is PharmaResearch Co Ltd's Revenue forecast?
Projected CAGR
36%
For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 30%. The projected CAGR for the next 3 years is 36%.
What is PharmaResearch Co Ltd's Operating Income forecast?
Projected CAGR
43%
For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 27%. The projected CAGR for the next 3 years is 43%.
What is PharmaResearch Co Ltd's Net Income forecast?
Projected CAGR
47%
For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 26%. The projected CAGR for the next 3 years is 47%.
